Searchable abstracts of presentations at key conferences in endocrinology

ea0097017 | Section | BES2023

Unilateral mydriasis as a first presentation of pituitary macroadenoma

Tim Ailliet , Axelle Cools , Haecke Helena Van , Nikolaas Vantomme , Sylvie Vandelanotte , Bruel Annick Van Den

Background: Pituitary adenomas are the most prevalent tumours in the sellar region and can either be functioning, with autonomous pituitary hormone secretion, or non-functioning. Clinically evident adenomas occur in 1 in 1,100 in the general population. Pituitary adenomas have traditionally been subdivided into microadenomas (<10 mm) or macroadenomas (≥ 10 mm), with macroadenomas comprising 48% of clinically relevant adenomas. Non-functioning pituita...

ea0098c12 | Clinical – Chemo/SSA/Biologics | NANETS2023

Real world use of virtual care for treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs)

J Phillips William , Pradier Michelle , Goodwin Rachel , Vickers Michael , Asmis Tim

Background: Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are a relatively rare group of tumors. Traditionally, management of unresectable GEP-NETs was performed by in-person assessment at specialized regional cancer centers. The COVID-19 pandemic resulted in an unprecedent shift towards virtual care. The aim of this study is to evaluate the use of virtual care for GEP-NETs after the COVID-19 pandemic at a high-volume academic cancer center. Me...

ea0099rc6.2 | Rapid Communications 6: Thyroid | Part I | ECE2024

Interpretation of TPOAb measurement in pregnancy: An individual participant data meta-analysis

Liu Yindi , Osinga Joris , Feldt-Rasmussen Ulla , Bliddal Sofie , Peeters Robin , Derakhshan Arash , Korevaar Tim

Objective: Thyroid peroxidase antibody (TPOAb) positivity is the most important risk factor for overt/subclinical hypothyroidism and partly guides levothyroxine treatment indications during pregnancy. TPOAb positivity is usually defined by manufacturer cutoffs which are typically derived in non-pregnant populations with concentrations ≥95th percentile. Besides the general lack of assay uniformity, current TPOAb positivity cutoffs are likely to underestimate gestational t...

ea0099p369 | Thyroid | ECE2024

The association of gestational thyroid function and thyroid autoimmunity with offspring neurodevelopment: an individual participant meta-analysis

Osinga Joris , Warringa Leonie , on Thyroid and Pregnancy Consortium , Peeters Robin , Korevaar Tim

Objective: Adequate thyroid hormone availability is essential for foetal neurodevelopment. While overt maternal hypothyroidism is associated with lower offspring IQ, recent studies suggested an inverse U-shaped association, with suboptimal offspring neurodevelopment for both the lower and higher thyroid function range. Our aim is to investigate the association of gestational thyroid function with offspring IQ scores, assess if this association is different based on the gestati...

ea0077oc6.1 | Thyroid | SFEBES2021

Adjuvant Rituximab – exploratory trial in young people with Graves’ disease

Cheetham Tim , Cole Michael , Abinun Mario , Alalhabadia Amit , Barratt Tim , Davies Justin , Dimitri Paul , Drake Amanda , Mohamed Zainaba , Murray Robert , Steele Caroline , Zammitt Nicola , Carnell Sonya , Prichard Jonathan , Watson Gillian , Hambleton Sophie , Matthews John , Pearce Simon

Objective: Remission rates in young people with Graves’ hyperthyroidism are <25% after a 2-yr course of thionamide antithyroid drug (ATD). Immunomodulatory agents might improve outcome by facilitating immune tolerance. We explored whether rituximab (RTX) would increase remission rates when administered with a short course of ATD.Design: This was an open label multi-centre single arm phase 2 trial in newly presenting young people (12-20y) with Gr...

ea0084op-02-10 | Oral Session 2: Pregnancy | ETA2022

Phthalate exposure is associated with thyroid function during pregnancy through a novel pathway as a hcg disruptor

Derakhshan Arash , Shu Huan , Broeren Maarten , Demeneix Barbara , H. Lindh Christian , Peeters Robin , Bornehag Carl-Gustaf , Korevaar Tim

Phthalate exposure is associated with thyroid function during pregnancy through a novel pathway as a hCG disruptor.Objectives: hCG stimulates thyroid function in pregnancy and phthalates are known thyroid disruptors. We investigated if phthalate exposure could act as a thyroid disruptor through affecting hCG.Methods: This study was embedded in the prospective Swedish Environmental Longitudinal, Mother and child, Asthma and allergy ...

ea0085oc6.3 | Oral Communications 6 | BSPED2022

Use of 24 weekly decapeptyl SR in central precocious puberty is well-tolerated and efficacious – a two centre study

Lake Lydia , Kothayan Bharathy , Sharratt Isabel , O'Sullivan Jacquelin , Russell Julia , Sharma Veena , Cheetham Tim , Wood Claire , Howard Sasha

Central precocious puberty (CPP) is a common and well-recognised condition characterised by premature activation of the hypothalamic-pituitary-gonadal axis, with consequent potential adverse health and psychosocial outcomes. Standard management of CPP is with periodic injections of gonadotropin-releasing hormone analogue therapy. Decapeptyl SR (Triptorelin pamoate) has for several years been available as a long-acting (12-weekly, 11.25 mg) preparation, but more recently is ava...

ea0086p301 | Adrenal and Cardiovascular | SFEBES2022

Feasibility of primary aldosteronism screening in primary care – prevalence and concordance with secondary care assessment

Marie Hannon Anne , Dissanayake Harsha , Warner Bronwen , Mihai Radu , James Tim , Ray David , Shine Brian , Pal Aparna

Background: Primary aldosteronism (PA) is the commonest cause of secondary hypertension. Reported prevalence is about 30% in hypertensive population. Success of screening for PA in general practice (GP) is unknown. Expected challenges include laboratory access, transport issues and interfering medications.Aims: We aimed to report prevalence of PA in a large primary care cohort, the correlation between GP and in-hospital ARR and to assess if a change in r...

ea0090p666 | Endocrine-related Cancer | ECE2023

A rare case of immunotherapy related adrenalitis

Ganawa Shawg , Mashamba Chiedza , Ilyas Waqas , Higham Claire , Cooksley Tim , Hoong Ho Jan , Adam Safwaan , Dhage Shaishav

Introduction: Immunotherapy has transformed the outcomes of various cancers. Monoclonal antibodies against cytotoxic T lymphocyte antigen 4 (CTLA4), programmed cell death 1 (PD1) and its ligand, PDL1 target mainly T cells, unleashing the immune system against tumour cells. Immune checkpoint inhibitor therapy results in a variety of immune related adverse events, including various endocrinopathies. Thyroid disorders, pituitary disorders are relatively more common compared to pr...

ea0090p138 | Pituitary and Neuroendocrinology | ECE2023

Post operative copeptin does not predict occurrence of the syndrome of inappropriate antidiuresis (SIAD) after pituitary transsphenoidal surgery

Efthymiadis Agathoklis , Rostom Hussam , James Tim , Shine Brian , Guha Nishan , Cudlip Simon , Christ-Crain Mirjam , Pal Aparna

Introduction: The incidence of the syndrome of inappropriate antidiuresis (SIAD) post pituitary surgery is estimated at 3-20% with the condition potentially leading to significant morbidity and prolonged admission. Copeptin, a surrogate marker for vasopressin activity, has been shown to be a diagnostic tool in the diagnosis of AVP deficiency (formerly known as diabetes insipidus) post pituitary surgery. There is limited data regarding the utility of copeptin in predicting SIAD...